ECO Animal Health Group (EAH) Share Price, News & Analysis

Company Overview

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

Key Stats

• Today's Range: 63.75 to 66
• 50-Day Range: 65 to 111.35
• 52-Week Range: 60 to 135
• Volume: 35,330 shs
• Average Volume: 109,394 shs
• Market Capitalization: £44.71 million
• P/E Ratio: 3,300.00
• Dividend Yield: 1.52%
• Price Target: N/A
• Consensus Rating: Buy

EAH Stock Analysis - Frequently Asked Questions

How have EAH shares performed this year?

ECO Animal Health Group's stock was trading at GBX 108.50 at the start of the year. Since then, EAH shares have decreased by 41.0% and is now trading at GBX 64.05.
View the best growth stocks for 2024 here.

How do I buy shares of ECO Animal Health Group?

Shares of EAH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of ECO Animal Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ECO Animal Health Group investors own include Intrepid Potash (IPI), Allena Pharmaceuticals (ALNA), Anpario (ANP), Iovance Biotherapeutics (IOVA), Navios Maritime (NM), Ampliphi Biosciences (APHB) and Actinium Pharmaceuticals (ATNM).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: LON:EAH
• CUSIP: N/A
• CIK: N/A
• Web: www.ecoanimalhealthgroupplc.com
• Phone: +44-20-83362900
• Fax: N/A
• Employees: 234
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.02
• Trailing P/E Ratio: 3,202.50
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £1.05 million
• Net Margins: 1.17%
• Pretax Margin: N/A
• Return on Equity: 2.13%
• Return on Assets: 2.14%

Debt

• Debt-to-Equity Ratio: 4.31
• Current Ratio: 2.96
• Quick Ratio: 2.14

Sales & Book Value

• Annual Sales: £89.42 million
• Price / Sales: 0.49
• Cash Flow: GBX 10.58 per share
• Price / Cash Flow: 6.05
• Book Value: GBX 124 per share
• Price / Book: 0.52

Miscellaneous

• Outstanding Shares: 67,740,000
• Free Float: N/A
• Market Cap: £43.39 million
• Optionable: Not Optionable
• Beta: -0.05